Recent advances of highly selective CDK4/6 inhibitors in breast cancer

Uncontrolled cell division is the hallmark of cancers. Full understanding of cell cycle regulation would contribute to promising cancer therapies. In particular, cyclin-dependent kinases 4/6 (CDK4/6), which are pivotal drivers of cell proliferation by combination with cyclin D, draw more and more at...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Hanxiao, Yu, Shengnan, Liu, Qian, Yuan, Xun, Mani, Sridhar, Pestell, Richard G., Wu, Kongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404666/
https://www.ncbi.nlm.nih.gov/pubmed/28438180
http://dx.doi.org/10.1186/s13045-017-0467-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404666/
https://www.ncbi.nlm.nih.gov/pubmed/28438180
http://dx.doi.org/10.1186/s13045-017-0467-2

Ejemplares similares